![M2 macrophages derived from Imprime PGG-treated monocytes significantly... | Download Scientific Diagram M2 macrophages derived from Imprime PGG-treated monocytes significantly... | Download Scientific Diagram](https://www.researchgate.net/profile/Anissa-Chan-2/publication/279993186/figure/fig2/AS:272572331851831@1441997716932/M2-macophages-derived-from-Imprimer-PGG-treated-monocytes-have-reduced-expression-of_Q320.jpg)
M2 macrophages derived from Imprime PGG-treated monocytes significantly... | Download Scientific Diagram
![M2 macrophages derived from Imprime PGG-treated monocytes significantly... | Download Scientific Diagram M2 macrophages derived from Imprime PGG-treated monocytes significantly... | Download Scientific Diagram](https://www.researchgate.net/profile/Anissa-Chan-2/publication/279993186/figure/fig3/AS:272603231289363@1442005083441/M2-macrophages-derived-from-Imprime-PGG-treated-monocytes-significantly-enhance-T-cell_Q640.jpg)
M2 macrophages derived from Imprime PGG-treated monocytes significantly... | Download Scientific Diagram
![Imprime PGG, a yeast β-glucan immunomodulator, has the potential to repolarize human monocyte-derived M2 macrophages to M1 phenotype | Journal for ImmunoTherapy of Cancer Imprime PGG, a yeast β-glucan immunomodulator, has the potential to repolarize human monocyte-derived M2 macrophages to M1 phenotype | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/2/Suppl_3/P191/F3.medium.jpg)
Imprime PGG, a yeast β-glucan immunomodulator, has the potential to repolarize human monocyte-derived M2 macrophages to M1 phenotype | Journal for ImmunoTherapy of Cancer
![Imprime PGG, a yeast β-glucan immunomodulator, has the potential to repolarize human monocyte-derived M2 macrophages to M1 phenotype | Journal for ImmunoTherapy of Cancer Imprime PGG, a yeast β-glucan immunomodulator, has the potential to repolarize human monocyte-derived M2 macrophages to M1 phenotype | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/2/Suppl_3/P191/F2.medium.jpg)
Imprime PGG, a yeast β-glucan immunomodulator, has the potential to repolarize human monocyte-derived M2 macrophages to M1 phenotype | Journal for ImmunoTherapy of Cancer
![Imprime PGG, a yeast β-glucan immunomodulator, has the potential to repolarize human monocyte-derived M2 macrophages to M1 phenotype | Journal for ImmunoTherapy of Cancer | Full Text Imprime PGG, a yeast β-glucan immunomodulator, has the potential to repolarize human monocyte-derived M2 macrophages to M1 phenotype | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2051-1426-2-S3-P191/MediaObjects/40425_2014_Article_642_Fig3_HTML.jpg)